The Dialogue will explore the health challenges of Australia’s ageing population. Entrepreneurs, decision makers, government officials, researchers, academics and business leaders will have the opportunity to exchange ideas and together explore:
The 2017 Dialogue will examine if health technology can help Australia rise to the challenge of adapting to the ageing face of the nation, in order to mitigate issues of rising and shifting healthcare costs and needs. For more details on the topics to be explored please download the draft program (updated 22 February 2017) and/or download the Issues Paper (PDF).
It will highlight ATSE’s consistent commitment to leading the public discussion on Australia’s future prosperity with a focus on using the best of Australian and international technologies to address our national challenges.
Professor Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer.
He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is a member of the Commonwealth Science Council and chair of the federal governments Medical Research Future Fund.
He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008 and was elected Fellow of the Royal Society of London in 2012.
Professor Reynolds is Director of the Medical Device Research Institute (MDRI) and the Medical Device Partnering Program (MDPP) as well as Deputy Dean of the School of Computer Science, Engineering and Mathematics at Flinders University. She is one of Australia’s leading researchers in biomedical engineering, a member of the Australian Medical Research Advisory Board, Chair of the ATSE Health Technology Forum and member of the Therapeutic Goods Administration’s Advisory Committee on Medical Devices.
Professor Reynolds was named South Australian Scientist of the Year 2012, Australian Professional Engineer of the Year (2010) and one of Australia’s Top 100 Most Influential Engineers (2015/2013/2012) by Engineers Australia.
In 2014, she was awarded the Outstanding Achievement Award from the Medical Technology Association of Australia MTAA. The Award acknowledges an individual’s significant and outstanding contribution to the Australian medical technology industry.
Dr Rogers is an engineer and Senior Manager of the Cognitive Health & Life Sciences Research team at IBM Research – Australia, where she leads a large, multi-disciplinary team in the area of data-driven healthcare. This spans cognitive health sciences and medical image analytics right through to the development of computational tools to support routine clinical use of next generation sequencing. In her role, she is responsible for defining and driving the research agenda in the health and life sciences portfolio.
Dr Rogers, whose Monash Engineering PhD focused on the exploitation of micro and nanoscale phenomena for diagnostic and drug discovery applications, is passionate about the convergence of technology and health, and the transformative impact it can have on the sector. She has wide experience in the health sector, from designing nanobiosensors and other medical devices, to managing large research teams on health and life sciences projects.
Subscribe to the event e-list for notification when more details are released.
It also incorporates ATSE’s Annual Innovation Dinner on 14 June where the Clunies Ross Awards for innovation commercialisation will be presented. These exciting awards bring together Australia’s top leaders and innovators from research, industry, academia and government and provide a valuable networking opportunity at the nation’s premier annual awards for innovation commercialisation.
Sponsorship opportunities are available for both the Innovation Dinner and the Dialogue.
Registrations close 5pm Tuesday 6 June 2017. Late registrations will not be accepted.
We understand that circumstances may change which have an effect on your ability to attend the event after it has been booked and paid for. Should your attendance plans change the following will apply:
Name change: A substitute delegate can be nominated to attend in your place at any time up to 24 hours prior to the start of the event. There is no fee for a change in delegate name up to this point. A name change within 24 hours of the start of the event will incur a 25 per cent administration fee.
Cancellation: Should you be unable to find a replacement and seek a refund, the following applies:
All name changes or cancellations must be advised in writing by email to firstname.lastname@example.org
View the Event Cancellation and Refund Policy.
Enhancing Australia's prosperity through technology and innovation